KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cardlytics (CDLX) Other Operating Expenses (2017 - 2025)

Historic Other Operating Expenses for Cardlytics (CDLX) over the last 8 years, with Q3 2025 value amounting to -$320000.0.

  • Cardlytics' Other Operating Expenses changed N/A to -$320000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $4.8 million, marking a year-over-year decrease of 9708.47%. This contributed to the annual value of -$6.6 million for FY2023, which is N/A changed from last year.
  • Latest data reveals that Cardlytics reported Other Operating Expenses of -$320000.0 as of Q3 2025.
  • Over the past 5 years, Cardlytics' Other Operating Expenses peaked at $430.3 million during Q4 2022, and registered a low of -$444000.0 during Q1 2022.
  • Moreover, its 4-year median value for Other Operating Expenses was $63.1 million (2021), whereas its average is $81.4 million.
  • In the last 5 years, Cardlytics' Other Operating Expenses tumbled by 10088.84% in 2022 and then skyrocketed by 628693.69% in 2023.
  • Over the past 4 years, Cardlytics' Other Operating Expenses (Quarter) stood at $76.1 million in 2021, then soared by 465.29% to $430.3 million in 2022, then tumbled by 61.5% to $165.7 million in 2023, then crashed by 100.19% to -$320000.0 in 2025.
  • Its Other Operating Expenses stands at -$320000.0 for Q3 2025, versus -$200000.0 for Q2 2025 and $5.4 million for Q1 2025.